← Open Payments lookup

WILLIAM FULLER: Open Payments

NPI 1326440488 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$745 in 36 payments from 14 companies in 2025. Trend: 2023 $502 · 2024 $739 · 2025 $745

Food & beverage: $745
CompanyPaymentsAmount
PFIZER INC.6$122
Novartis Pharmaceuticals Corporation5$112
Boehringer Ingelheim Pharmaceuticals, Inc.4$107
Alnylam Pharmaceuticals Inc.4$87
Amgen Inc.4$60
Medtronic, Inc.2$52
Boston Scientific Corporation2$42
AstraZeneca Pharmaceuticals LP2$37
E.R. Squibb & Sons, L.L.C.1$27
Abbott Laboratories1$24

Products named: ELIQUIS, LEQVIO, JARDIANCE, AMVUTTRA, REPATHA, FARXIGA, LINQ II, CAMZYOS.

Industry payments across CA — which companies pay providers there.